COMMUNIQUÉS West-GlobeNewswire

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report
12/02/2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended [...]
This Valentine’s Day, Oxford Treatment Center Underscores the Power of Couples Recovery
12/02/2026
ETTA, Miss., Feb. 12, 2026 (GLOBE NEWSWIRE) -- As Valentine's Day approaches, Oxford Treatment Center emphasizes the critical role of joint recovery for couples affected by substance misuse, offering a specialized [...]
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
12/02/2026
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
12/02/2026
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 Company to Host Conference Call with Live Q&A, February 26, 2026, at 4:30pm ET / 22:30 CET IRVINE, [...]
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
12/02/2026
This press release is issued solely to correct a date from an AIM press release dated February 11, 2026. The Subscription Rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on February 27, 2026, [...]
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
12/02/2026
ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
12/02/2026
AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31 [...]
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
12/02/2026
ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. “As we close out the [...]
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
12/02/2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI ( [...]
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
12/02/2026
Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product Seeking to develop and commercialize new tethered continuous [...]
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/02/2026
LEXINGTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to [...]
NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams
12/02/2026
VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class [...]
Pennant Announces Fourth Quarter and Year-End 2025 Earnings Release and Call
12/02/2026
EAGLE, Idaho, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
12/02/2026
Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult [...]
Canadian Red Cross launches appeal to support people impacted by the tragedy in Tumbler Ridge, B.C.
12/02/2026
OTTAWA, Ontario, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working to support those impacted by the tragedy in Tumbler Ridge, B.C., and has launched the Tumbler Ridge Tragedy Appeal. Money raised will [...]
La Croix-Rouge canadienne recueille des dons pour venir en aide aux personnes éprouvées par la tragédie à Tumbler Ridge, en Colombie-Britannique
12/02/2026
OTTAWA, Ontario, 12 févr. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne s’emploie à soutenir les personnes touchées par la tragédie survenue à Tumbler Ridge, en Colombie-Britannique. L’organisation a mis sur pied [...]
FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
12/02/2026
White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to [...]
Beacon Behavioral Partners Expands into South Carolina with Carolina Psychiatry
12/02/2026
New partner brings advanced depression treatments to Anderson, Greenville, Seneca, and Spartanburg BATON ROUGE, La., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners (BBP), a physician-driven organization [...]
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
12/02/2026
Ipsen reported US$88M of Iqirvo® net sales in PBC for 4Q25, bringing 2025 sales to US$208M, triggering the first commercial milestone payment to GENFIT ahead of schedule 1 Ipsen confirmed its commitment to launch a [...]

Pages